For example, the ADH-1 (Exherin), is an anticancer peptide distributed by Adhex Technologies®, which targets N-cadherin and induced partial and complete protective responses in patients with metastatic melanoma (49). This evidence concerns the gene CDH2 and metastatic melanoma.